Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational drug discovery, with proprietary, proteome-wide SAR delivering ...

We recently published a list of Top 8 AI News Updates Driving Markets Today. In this article, we are going to take a look at where Predictive Oncology Inc. (NASDAQ:POAI) stands against other top AI ...

In addition, the Group's subsidiary Viva Biotech Shanghai was successfully restructured into a joint stock limited company on September 27, 2024, as the Group currently holds approximately 72.9% of ...

Presented a poster highlighting the use of the Company's Magellan™ drug discovery platform to identify allosteric inhibitors ...

The last time a new class of antibiotics reached the market was nearly three decades ago - but that could soon change, thanks to a discovery by researchers at McMaster University.

BMS says it is combining AI and machine learning with its researchers’ expertise in drug targets and mechanisms of action, to ...

The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

Over the years, there has been an increasing demand for an effective and cost-efficient drug discovery process. The study of ...

Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...

In the rapidly evolving field of drug discovery, single-cell analysis has become an invaluable tool for understanding cellular heterogeneity and molecular | Drug Discovery And Development ...

During a health-focused event in New York on Tuesday, Google announced the development of a new collection of “open” AI ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.